MedPath

S-Ketamine to reduce pain associated with negative pressure wound therapy dressing change

Conditions
adult patients undergoing negative pressure wound therapy dressing change
MedDRA version: 16.1Level: LLTClassification code 10074212Term: Vacuum assisted wound closureSystem Organ Class: 100000004865
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2013-005114-35-FI
Lead Sponsor
Helsinki UNiversity Central Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

adult patients undergoing negative pressure wound therapy dressing change
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 23
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

BMI >40, ischemic cardiac disease, increased intracranial pressure, increased intraocular pressure, graviidity, lactation, hypersensitivity or allegy to ketamine, fentanyl or midazolam, severe psychiatric disease, drug addiction, unability to use NRS-pain scale

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: to reduce pain and the need of rescue fentanyl during negative pressure wound therapy dressing change associated pain;Secondary Objective: evaluating haemodynamic changes and possible confusion;Primary end point(s): pain during negative pressure wound therapy dressing change, the need of rescue fentanyl (an opiodi) during the procedure);Timepoint(s) of evaluation of this end point: pain at the beginning of the procedure and at 15 minutes, 30 minutes, 45 minutes and 60 minutes, after 3 months
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): evaluation of hemodynamic changes /heart rate, blood pressure) and oxygen saturation, evaluation of confusion;Timepoint(s) of evaluation of this end point: 15, 30, 45 and 60 minutes for RR, p, Sp02<br>15 and 60 minutes for confusion using RASS-scale (Richmond Agitation Sedation scale)
© Copyright 2025. All Rights Reserved by MedPath